Skip to content

Released Feb 26, 2018, after the close

10-K filed Feb 26, 2018, 57 days after period end · 0001564590-18-003256

Q4 2017 · 10-K
Revenue$116.90M+7.7% vs Q4 2016+11.1% vs Q3 2017
Net Income$1.57MN/M vs Q4 2016−54.6% vs Q3 2017
EPS Diluted$0.08N/M vs Q4 2016−57.9% vs Q3 2017
Gross Profit$93,334,000+9.5%
Operating Income$17,860,000+140.8%
Operating Cash Flowderived$29,847,000+44.3%
Free Cash Flowderived$26,623,000+54.9%
Margins · derived
Gross margin79.8%+1.3 pt vs Q4 2016
Operating margin15.3%+8.4 pt vs Q4 2016
Net margin1.3%+4.3 pt vs Q4 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2017Q4 2016Q4 2015Q4 2014
Revenue$116.90M$108.54M$104.62M$100.28M
Net Income$1.57M-$3.24M$3.37M-$5.80M
EPS Diluted$0.08-$0.18$0.18-$0.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR